Forbes J M & Co LLP
- SEC CIK
- 0001067532
- Latest filing
- Jul 20, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Forbes J M & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,704
- Value
- $906.6K
- % of portfolio
- 0.1%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,704 | $906.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,704 | $626.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,704 | $676.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,704 | $449.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,704 | $386.7K | <0.1% | −136−3.5% | Reduced | Holders |
| Q1 2025 | 3,840 | $447.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,840 | $324.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3,840 | $345.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,840 | $309.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,840 | $306.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,840 | $305.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,840 | $268.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,840 | $276.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,840 | $237.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,840 | $296.0K | <0.1% | +3,840 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −3,840−100.0% | Sold out | Holders |
| Q2 2021 | 3,840 | $259.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3,840 | $217.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.